Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
AbbVie announced today topline results from the singlearm Phase LUMINOSITY trial evaluating telisotuzumabvedotin TelisoV in patients with cMet protein overexpression epidermal growth factor receptor
Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide announced today positive topline results from a pharmacokinetic
Evaxion Biotech AS a clinicalstage TechBio company specializing in developing AIImmunology powered vaccines proudly announces the presentation
Carisma Therapeutics Inc a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies today announced the clearance
SpringWorks Therapeutics Inc a commercialstage biopharmaceutical company focused on severe rare diseases and cancer announced today that the US Food and Drug Administration
INmune Bio Inc a clinical stage immunology company dedicated to advancing treatments that leverage the patients innate immune system to combat disease
Vertex Pharmaceuticals today announced that the European Medicines Agency has validated a Type II variation application to the Marketing Authorization for KAFTRIO
Regeneron Pharmaceuticals Inc and Sanofi today announced that the second Dupixent investigational Phase chronic obstructive pulmonary disease trial showed that Dupixent
Novo Nordisk today announced the investment of more than billion Danish kroner starting in to expand the existing production site in Chartres France for the current and future product
Sandoz the global leader in generic and biosimilar medicines today announces the launch of Hyrimoz citratefree high concentration formulation HCF mgmL in Europe The medicine
